Millennium Management’s BioNTech BNTX Stock Holding History

Millennium Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-80,000	Closed	-$7.62M	–	5738
2025 Q4	$7.62M	Buy	+80,000	New	+$8.06M	﹤0.01%	2557
2024 Q4	–	Sell	-50,200	Closed	-$5.96M	–	5968
2024 Q3	$5.96M	Buy	50,200 +5,200	+12%	+$478K	﹤0.01%	2693
2024 Q2	$3.62M	Buy	45,000 +9,300	+26%	+$850K	﹤0.01%	3025
2024 Q1	$3.29M	Buy	35,700 +12,800	+56%	+$1.23M	﹤0.01%	3284
2023 Q4	$2.42M	Sell	22,900 -15,100	-40%	-$1.52M	﹤0.01%	3447
2023 Q3	$4.13M	Sell	38,000 -2,900	-7%	-$321K	﹤0.01%	2877
2023 Q2	$4.41M	Buy	40,900 +38,300	+1,473%	+$4.31M	﹤0.01%	2780
2023 Q1	$324K	Buy	+2,600	New	+$357K	﹤0.01%	4856

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Millennium Management's BNTX Position: Q1 2026 in Review

Millennium Management reduced its BioNTech (BNTX) stake by 87% in Q1 2026, selling an estimated $24.4M and leaving 35,372 shares worth $3.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3430.

Millennium Management first reported a position in BNTX in Q4 2019 and has held it in 25 quarters since. The position peaked at $84.6M in Q3 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Millennium Management held 35,372 shares of BioNTech worth $3.14M as of Q1 2026.
Millennium Management sold 236,993 BioNTech shares in Q1 2026, an estimated $24.4M.
BioNTech made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3430 holding.
Millennium Management first reported a position in BioNTech in Q4 2019 and has held it in 25 quarters since.
Millennium Management's BioNTech position peaked at $84.6M in Q3 2021.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.